What This Bill Does · Plain English
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
Action Timeline
2025-09-16
ASSUMING FIRST SPONSORSHIP - Mr. Walkinshaw asked unanimous consent that he may hereafter be considered as the first sponsor of H.R. 1670, a bill originally introduced by Representative Connolly, for the purpose of adding cosponsors and req
2025-02-27
Introduced in House
2025-02-27
Referred to the House Committee on Oversight and Government Reform.
2025-02-27
Introduced in House
Frequently Asked Questions
Did HR.1670 pass?
HR.1670 is still alive. Current stage: PASSED_ONE. Pass likelihood: 36%.
Who sponsored HR.1670?
HR.1670 was sponsored by Gerald Connolly (D-Virginia).
Full Bill Text
119 HR 1670 IH: Family Building FEHB Fairness Act U.S. House of Representatives 2025-02-27 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 1670 IN THE HOUSE OF REPRESENTATIVES February 27, 2025 Mr. Connolly (for himself, Ms. Norton , and Ms. Wasserman Schultz ) introduced the following bill; which was referred to the Committee on Oversight and Government Reform A BILL To require Federal employee health benefit plans to include assisted reproductive treatment benefits, and for other purposes. 1. Short title This Act may be cited as the Family Building FEHB Fairness Act . 2. Fertility treatment benefits (a) In general Section 8904 of title 5, United States Code, is amended— (1) in subsection (a)— (A) in paragraph (1), by adding at the end the following new subparagraph: (G) Fertility treatment benefits. ; and (B) in paragraph (2)— (i) by redesignating subparagraph (F) as subparagraph (G); and (ii) by inserting after subparagraph (E) the following new subparagraph: (F) Fertility treatment benefits. ; and (2) by adding at the end the following new subsection: (c) In this section, the term fertility treatment means— (1) preservation of human oocytes, sperm, or embryos for later reproductive use; (2) artificial insemination, including intravaginal insemination, intracervical insemination, and intrauterine insemination; (3) assisted reproductive technology, including in vitro fertilization and other treatments or procedures in which reproductive genetic material, such as oocytes, sperm, fertilized eggs, and embryos, are handled, when clinically appropriate; (4) genetic testing of embryos; (5) medications prescribed or obtained over-the-counter, as indicated for fertility; (6) gamete donation; and (7) such other information, referrals, treatments, procedures, medications, laboratory services, technologies, and services relating to fertility as the Director of the Office of Personnel Management, in coordination with the Secretary of Health and Human Services, determines appropriate. . (b) Effective date The amendments made by this Act shall take effect on the date that is 1 year after the date of the enactment of this Act.
Loading intelligence layer…